# QY Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qy-genomics

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.qynode.com
- Total disclosed funding: $0.8M
- Latest round: Angel (May 23, 2015)
- Investors on record: 1

## About

Based in Beijing, China, and established in 2014, QY Genomics is a biotechnology company that provides a bioinformatics big data platform via utilizing artificial intelligence technology. The founder and CEO of the company, Qibin Luo, graduated from the Technical University of Munich and is a special research fellow of the Internet Medical Association of China. The third-party independent laboratories and innovation laboratories are distributed in Beijing, Tianjin, and other places. In May 2015, it raised CNY 5 million in angel funding. As of 2024, the company has acquired more than 160 intellectual property rights, published more than 400 articles, and won more than 10 corporate honors including National High Tech Enterprise and Zhongguancun High Tech Enterprise.

The company is committed to the development of intelligent detection and precision medicine-related products, multi-omics artificial intelligence system development, and bioinformatics cloud applications. The business includes multi-omics data management, precision intelligent health management all-in-one machines, and multi-omics interpretation and modeling.

## Funding rounds

- Angel, May 23, 2015, $0.8M — Kaitai Capital

## Investors

- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Angel